Previously, coagulation disturbance has been presented in MPI-CDG, ALG12-CDG, ALG2-CDG, ALG1-CDG, and B4GALT1-CDG, and it has been one of the most commonly reported clinical symptoms in CDG patients. Here, ALG2 is linked to congenital disorder of glycosylation.